These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

178 related items for PubMed ID: 1324642

  • 1. Synergistic activity of azithromycin and pyrimethamine or sulfadiazine in acute experimental toxoplasmosis.
    Derouin F, Almadany R, Chau F, Rouveix B, Pocidalo JJ.
    Antimicrob Agents Chemother; 1992 May; 36(5):997-1001. PubMed ID: 1324642
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. In-vitro and in-vivo activities of roxithromycin in combination with pyrimethamine or sulphadiazine against Toxoplasma gondii.
    Romand S, Bryskier A, Moutot M, Derouin F.
    J Antimicrob Chemother; 1995 Jun; 35(6):821-32. PubMed ID: 7559193
    [Abstract] [Full Text] [Related]

  • 4. A clinical-parasitological monotherapy cure in the treatment of experimental infection by a highly virulent strain of Toxoplasma gondii.
    de Diego JA, Penin P, Arribas JR, Vázquez E, Vázquez JJ.
    Folia Microbiol (Praha); 1996 Jun; 41(6):513-6. PubMed ID: 9131805
    [Abstract] [Full Text] [Related]

  • 5. Synergistic combination of azithromycin and sulfadiazine for treatment of toxoplasmosis in mice.
    Araujo FG, Lin T, Remington JS.
    Eur J Clin Microbiol Infect Dis; 1992 Jan; 11(1):71-3. PubMed ID: 1314177
    [Abstract] [Full Text] [Related]

  • 6. The activity of atovaquone (566C80) in murine toxoplasmosis is markedly augmented when used in combination with pyrimethamine or sulfadiazine.
    Araujo FG, Lin T, Remington JS.
    J Infect Dis; 1993 Feb; 167(2):494-7. PubMed ID: 8421189
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Determination of parasitic burden in the brain tissue of infected mice in acute toxoplasmosis after treatment by fluconazole combined with sulfadiazine and pyrimethamine.
    Sina S, Mohammad JM, Reza S, Anita M, Soudabeh E, Hadi M.
    Eur J Med Res; 2021 Jun 30; 26(1):65. PubMed ID: 34193287
    [Abstract] [Full Text] [Related]

  • 11. Study of treatment of congenital Toxoplasma gondii infection in rhesus monkeys with pyrimethamine and sulfadiazine.
    Schoondermark-van de Ven E, Galama J, Vree T, Camps W, Baars I, Eskes T, Meuwissen J, Melchers W.
    Antimicrob Agents Chemother; 1995 Jan 30; 39(1):137-44. PubMed ID: 7695295
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Efficacy of sulfadiazine and pyrimetamine for treatment of experimental toxoplasmosis with strains obtained from human cases of congenital disease in Brazil.
    Silva LA, Fernandes MD, Machado AS, Reis-Cunha JL, Bartholomeu DC, Almeida Vitor RW.
    Exp Parasitol; 2019 Jul 30; 202():7-14. PubMed ID: 31077733
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Evaluation of the efficacy of azithromycin and pyrimethamine, for treatment of experimental infection of mice with Toxoplasma gondii cystogenic strain].
    Lescano SA, Amato Neto V, Chieffi PP, Bezerra RC, Gakiya E, Ferreira CS, Braz LM.
    Rev Soc Bras Med Trop; 2004 Jul 30; 37(6):460-2. PubMed ID: 15765594
    [Abstract] [Full Text] [Related]

  • 16. Rifabutin is active in murine models of toxoplasmosis.
    Araujo FG, Slifer T, Remington JS.
    Antimicrob Agents Chemother; 1994 Mar 30; 38(3):570-5. PubMed ID: 8203856
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. In vitro and in vivo effects of rifabutin alone or combined with atovaquone against Toxoplasma gondii.
    Romand S, Della Bruna C, Farinotti R, Derouin F.
    Antimicrob Agents Chemother; 1996 Sep 30; 40(9):2015-20. PubMed ID: 8878573
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.